SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-093974
Filing Date
2023-08-21
Accepted
2023-08-21 17:01:09
Documents
2
Period of Report
2023-08-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2324240d1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2324240d1_3seq1.xml 3 1553
2 EXHIBIT 24 tm2324240d1_ex24.htm EX-24 6804
  Complete submission text file 0001104659-23-093974.txt   9841
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 9 METERS BIOPHARMA, INC. 8480 HONEYCUTT ROAD, SUITE 120 RALEIGH NC 27615
Business Address
Sensenig Bethany (Reporting) CIK: 0001899935 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35518 | Film No.: 231189858